Macrogenics (MGNX) Common Equity (2012 - 2026)
Macrogenics (MGNX) recorded Common Equity of $42.87 million in Q2 2026, down 8.0% from $46.62 million a year earlier but up 102.3% from the prior quarter.
Powered by 
Analysis
Macrogenics (MGNX) Common Equity (2012 - 2026) Analysis & Trends
At the end of FY2025, Macrogenics reported Common Equity of $55.59 million, down 52.1% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of -28.4% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $116.06 million in FY2024 (-24.0%), $152.61 million in FY2023 (+7.5%), $142.01 million in FY2022 (-40.7%) and $239.62 million in FY2021 (-19.0%).
- Quarterly Common Equity has ranged from $21.2 million in Q1 2026 to $291.44 million in Q3 2021 over the past five years.
- On a year-over-year basis, Common Equity has declined for ten consecutive quarters, with an average decline of 35.6% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 57.8% in Q3 2023, against a decline of 73.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $21.2 million (Q1 2026), $55.59 million (Q4 2025) and $67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Macrogenics | 258.40 Mn | -59.37 Mn | - | 42.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.87 Mn |
| Mar 31, 2026 | 21.20 Mn |
| Dec 31, 2025 | 55.59 Mn |
| Sep 30, 2025 | 67.00 Mn |
| Jun 30, 2025 | 46.62 Mn |
| Mar 31, 2025 | 79.12 Mn |
| Dec 31, 2024 | 116.06 Mn |
| Sep 30, 2024 | 120.07 Mn |
| Jun 30, 2024 | 57.82 Mn |
| Mar 31, 2024 | 106.15 Mn |
| Dec 31, 2023 | 152.61 Mn |
| Sep 30, 2023 | 193.98 Mn |
| Jun 30, 2023 | 171.54 Mn |
| Mar 31, 2023 | 109.27 Mn |
| Dec 31, 2022 | 142.01 Mn |
| Sep 30, 2022 | 122.96 Mn |
| Jun 30, 2022 | 142.48 Mn |
| Mar 31, 2022 | 178.21 Mn |
| Dec 31, 2021 | 239.62 Mn |
| Sep 30, 2021 | 291.44 Mn |
API Access
Macrogenics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();